Literature DB >> 35033299

The Impact of Social Determinants of Health on Lung Cancer Screening Utilization.

Donghoon Shin1, Michael D C Fishman2, Michael Ngo3, Jeffrey Wang3, Christina A LeBedis4.   

Abstract

PURPOSE: The purpose of this study was to understand how social determinants of health might influence lung cancer screening (LCS) adherence.
METHODS: All LCS low-dose CT appointments scheduled at an urban, tertiary care academic medical center in the New England region between January 1, 2015, and December 31, 2018, were included. Demographics, insurance type, information on social determinants of health, and appointment status were obtained from the electronic medical records. Multivariate logistic regression was performed to evaluate the associations between the appointment status and the explanatory variables.
RESULTS: During the study period, 2,797 patients had 4,747 scheduled LCS appointments. Forty-one percent of patients had at least one missed appointment, and 32.7% of all scheduled appointments were missed. The retention rate of patients after the baseline examination was approximately 50%. Self-reported Black race was independently associated with 1.5 times the odds of missing appointments compared with White race (P = .012). Patients with Medicaid had 6.1 times the odds of missing appointments compared with patients with private insurance and 4.6 times the odds of missing appointments compared with patients with Medicare (P < .0001). Housing insecurity was a risk factor for failing to follow up after the baseline examination, with an odds ratio of 5.3 (P = .0013).
CONCLUSIONS: The high rate of missed LCS appointments underscores the need to improve screening compliance. The identification of specific social determinants of health that contribute to disparities in access to LCS could empower policymakers, hospital systems, and providers to use targeted interventions to promote more equitable access.
Copyright © 2021 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung cancer screening; missed imaging opportunities; racial disparities; screening adherence; social determinants of health

Mesh:

Year:  2022        PMID: 35033299      PMCID: PMC8820269          DOI: 10.1016/j.jacr.2021.08.026

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  24 in total

1.  Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015.

Authors:  Ahmedin Jemal; Stacey A Fedewa
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

2.  Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas.

Authors:  Amy J H Kind; William R Buckingham
Journal:  N Engl J Med       Date:  2018-06-28       Impact factor: 91.245

Review 3.  No-shows in appointment scheduling - a systematic literature review.

Authors:  Leila F Dantas; Julia L Fleck; Fernando L Cyrino Oliveira; Silvio Hamacher
Journal:  Health Policy       Date:  2018-02-15       Impact factor: 2.980

4.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

5.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

6.  Screening for Lung Cancer: Effective Recruitment Methods.

Authors:  Christopher Lee
Journal:  AJR Am J Roentgenol       Date:  2017-12-20       Impact factor: 3.959

7.  Implementing an EHR-based Screening and Referral System to Address Social Determinants of Health in Primary Care.

Authors:  Pablo Buitron de la Vega; Stephanie Losi; Linda Sprague Martinez; Allison Bovell-Ammon; Arvin Garg; Thea James; Alana M Ewen; Marna Stack; Heloisa DeCarvalho; Megan Sandel; Rebecca G Mishuris; Stella Deych; Patrick Pelletier; Nancy R Kressin
Journal:  Med Care       Date:  2019-06       Impact factor: 2.983

8.  Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials.

Authors:  Samantha L Quaife; Mamta Ruparel; Jennifer L Dickson; Rebecca J Beeken; Andy McEwen; David R Baldwin; Angshu Bhowmik; Neal Navani; Karen Sennett; Stephen W Duffy; Jane Wardle; Jo Waller; Samuel M Janes
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

9.  Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.

Authors:  Phil A Crosbie; Haval Balata; Matthew Evison; Melanie Atack; Val Bayliss-Brideaux; Denis Colligan; Rebecca Duerden; Josephine Eaglesfield; Timothy Edwards; Peter Elton; Julie Foster; Melanie Greaves; Graham Hayler; Coral Higgins; John Howells; Klaus Irion; Devinda Karunaratne; Jodie Kelly; Zoe King; Judith Lyons; Sarah Manson; Stuart Mellor; Donna Miller; Amanda Myerscough; Tom Newton; Michelle O'Leary; Rachel Pearson; Julie Pickford; Richard Sawyer; Nick J Screaton; Anna Sharman; Maggi Simmons; Elaine Smith; Ben Taylor; Sarah Taylor; Anna Walsham; Angela Watts; James Whittaker; Laura Yarnell; Anthony Threlfall; Phil V Barber; Janet Tonge; Richard Booton
Journal:  Thorax       Date:  2018-11-12       Impact factor: 9.139

10.  Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.

Authors:  M Patricia Rivera; Hormuzd A Katki; Nichole T Tanner; Matthew Triplette; Lori C Sakoda; Renda Soylemez Wiener; Roberto Cardarelli; Lisa Carter-Harris; Kristina Crothers; Joelle T Fathi; Marvella E Ford; Robert Smith; Robert A Winn; Juan P Wisnivesky; Louise M Henderson; Melinda C Aldrich
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

View more
  1 in total

1.  Addressing Lung Cancer Screening Disparities: What Does It Mean to Be Centralized?

Authors:  Eduardo R Núñez; Matthew Triplette
Journal:  Ann Am Thorac Soc       Date:  2022-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.